Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Single Use Technologies

Manuel Carrondo's Biography

Manuel Carrondo, Professor, Universidade Nova de Lisboa

Chemical Engineer, 1971, Univ. Porto; Master of Sciences (1975) and Philosophy Doctor
(1979) Environmental Engineering, Imperial College of Science and Technology, U. London;
Habilitation, Chemical Engineering (1991), Univ. Nova de Lisboa.
Full Professor, Chemical and Biochemical Engineering, Faculty of Sciences and Technology,
Univ. Nova de Lisboa. Founder and earlier president (currently CEO) of IBET – Institute for
Experimental and Technological Biology (, founder and board member of the
Portuguese Academy of Engineering (1998-2001) and board member of the Euro CASE
(Council on Applied Science and Engineering) (1998-2001), chairman of the European Society
of Animal Cell Technology (ESACT) (1997-2001) and of Medical Biotechnology Section of the
European Federation of Biotechnology (EFB) (1999-2001), member and Vice- Chairman of
the External Advisory Group “Cell Factory” (Research Directorate General, European
Commission) (1998-2002), member of the Advisory Board of Max – Planck Institute for
Dynamics of Complex Technical Systems, Magdeburg, Amgen Bioprocessing Center, KGI,
Claremont, California, CEVEC Pharmaceuticals, Köln, PBS Biotech, California and CNIC -
Spanish National Center for Cardiovascular Research Carlos III, Spain.
Founder and CSO of GenIBET Biopharmaceuticals (2006-2008) (
Meeting Chairman of the ESACT 14th Meeting “Animal Cell Technology: From Vaccines to
Genetic Medicine”, Vilamoura, May 1996 and of the “3rd Recombinant Protein Production
Meeting: A comparative view on host physiology"", Tavira-Algarve (Portugal), November
2004. Visiting Professor at Carnegie-Mellon Univ. (1981), Massachusetts Institute of
Technology - MIT (1988), Geselchaft für Biotechnologische Forschung (1989 and 1993).
Supervised twenty-eight Ph.D. students (thesis defended) and published over one hundred
ninety papers in refereed international journals; Associate-Editor of Journal of
Biotechnology, member of the editorial board of Biotechnology and Bioengineering, Current
Gene Therapy and Biotechnology Letters; referee of Biotechnology Progress,
Cytotechnology, Applied Microbiology and Biotechnology, Enzyme and Microbial
Key areas of research interest: Animal Cell Technology and its application for human and
animal health ( Therapeutic and diagnostic recombinant proteins,
including fusion proteins; virus like particles and pseudo viruses as vaccination agents and
viruses (retro-, adeno-, lenti-) as deliverables for gene therapy; cell therapies and stem cells.
cGMP pilot plant scale-up and production development of biopharmaceuticals.

Manuel Carrondo Image

SUT Applications in Up – and Downstream Bioprocessing

Wednesday, 27 June 2012 at 14:15

Add to Calendar ▼2012-06-27 14:15:002012-06-27 15:15:00Europe/LondonSUT Applications in Up – and Downstream Bioprocessing

Comparative studies of different SU Bioreactors against traditional vessels carried out at pilot scale will be presented for the production of viruses for vaccines and gene therapy. For the same applications novel designs, based on scale down tools, for disposable membranes for purification will be described.

Add to Calendar ▼2012-06-27 00:00:002012-06-28 00:00:00Europe/LondonSingle Use